Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$24.74 - $35.13 $6,481 - $9,204
-262 Reduced 0.88%
29,396 $793,000
Q4 2023

Feb 13, 2024

SELL
$21.62 - $37.21 $5,232 - $9,004
-242 Reduced 0.81%
29,658 $1.06 Million
Q3 2023

Nov 13, 2023

BUY
$27.34 - $55.37 $18,755 - $37,983
686 Added 2.35%
29,900 $845,000
Q2 2023

Aug 04, 2023

BUY
$26.1 - $49.92 $82,632 - $158,046
3,166 Added 12.15%
29,214 $1.46 Million
Q1 2023

May 12, 2023

BUY
$18.09 - $27.61 $9,388 - $14,329
519 Added 2.03%
26,048 $685,000
Q4 2022

Feb 10, 2023

SELL
$16.24 - $26.38 $1,510 - $2,453
-93 Reduced 0.36%
25,529 $477,000
Q3 2022

Nov 14, 2022

BUY
$23.95 - $34.71 $8,669 - $12,565
362 Added 1.43%
25,622 $640,000
Q2 2022

Aug 12, 2022

BUY
$21.39 - $35.9 $59,036 - $99,084
2,760 Added 12.27%
25,260 $667,000
Q1 2022

May 13, 2022

SELL
$24.84 - $36.12 $39,321 - $57,177
-1,583 Reduced 6.57%
22,500 $768,000
Q4 2021

Feb 11, 2022

SELL
$33.38 - $59.25 $24,066 - $42,719
-721 Reduced 2.91%
24,083 $839,000
Q3 2021

Nov 12, 2021

SELL
$53.75 - $76.55 $31,658 - $45,087
-589 Reduced 2.32%
24,804 $1.36 Million
Q2 2021

Aug 13, 2021

BUY
$59.02 - $78.8 $463,543 - $618,895
7,854 Added 44.78%
25,393 $1.92 Million
Q1 2021

May 07, 2021

BUY
$64.61 - $113.09 $3,036 - $5,315
47 Added 0.27%
17,539 $1.34 Million
Q4 2020

Feb 12, 2021

BUY
$48.06 - $84.4 $1,730 - $3,038
36 Added 0.21%
17,492 $1.39 Million
Q3 2020

Nov 04, 2020

BUY
$46.87 - $93.33 $422,439 - $841,183
9,013 Added 106.75%
17,456 $829,000
Q2 2020

Aug 12, 2020

BUY
$36.12 - $91.57 $10,221 - $25,914
283 Added 3.47%
8,443 $773,000
Q1 2020

May 04, 2020

BUY
$26.6 - $52.99 $217,056 - $432,398
8,160 New
8,160 $352,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.22B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.